Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Topical EGCG for Prevention of Radiation-Induced Oral Mucositis
ChiCTR2100052871Phase 2Recruiting
- Sponsor
- Shandong Cancer Hospital
- Start
- Nov 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of epigallocatechin gallate in oral mucositis (OM) (2 arms), sponsored by Shandong Cancer Hospital. Primary endpoint: The efficiency of EGCG. Started Nov 2021; status: recruiting.
02
Drugs
epigallocatechin gallate
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on ChiCTR2100052871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052871.